Invention Grant
- Patent Title: Oxadiazoanthracene compounds for the treatment of diabetes
- Patent Title (中): 用于治疗糖尿病的恶二唑类化合物
-
Application No.: US12872580Application Date: 2010-08-31
-
Publication No.: US08524708B2Publication Date: 2013-09-03
- Inventor: Adnan M. M. Mjalli , Dharma Rao Polisetti , Thomas Scott Yokum , Kalpathy Santhosh , Mustafa Guzel , Christopher Behme , Stephen Thomas Davis
- Applicant: Adnan M. M. Mjalli , Dharma Rao Polisetti , Thomas Scott Yokum , Kalpathy Santhosh , Mustafa Guzel , Christopher Behme , Stephen Thomas Davis
- Applicant Address: US NC High Point
- Assignee: TransTech Pharma, Inc.
- Current Assignee: TransTech Pharma, Inc.
- Current Assignee Address: US NC High Point
- Agent Samuel B. Rollins
- Main IPC: C07D498/02
- IPC: C07D498/02 ; A61K31/5365
Abstract:
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof, wherein A, B, C, R, R1, R2, R3, R4 and R5 are as herein described, and wherein said methods of use include uses for the treatment and/or prevention of disorders and diseases, such as diabetes.
Public/Granted literature
- US20100324033A1 OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES Public/Granted day:2010-12-23
Information query
